ActI-ORF2 (SCO5088) is the chain-length factor (CLF, KSbeta) of the actinorhodin "minimal" type II polyketide synthase in Streptomyces coelicolor. It is the non-catalytic partner of the ketosynthase ActI-ORF1 (KSalpha): together they form the heterodimeric KS-CLF that polymerizes the poly-beta-keto chain of the aromatic polyketide antibiotic actinorhodin. CLF is descended from a ketosynthase but lacks an active site; it regulates the final polyketide chain length, while the KS subunit carries out chain initiation and elongation. Chain elongation and the first cyclization occur within an amphipathic tunnel at the KS-CLF heterodimer interface (PMID:15286722; PDB 1TQY). This makes ActI-ORF2 a structural/specificity subunit that is only functional as part of the assembled KS-CLF complex, directly analogous to PqsB in the P. aeruginosa PqsBC condensing enzyme.
Definition: The function of a catalytically inactive ketosynthase-like (KSbeta/CLF) subunit that, as part of a type II polyketide synthase (KS-CLF) complex, determines the number of chain-extension cycles and hence the final length of the nascent polyketide chain, without itself catalyzing condensation.
Justification: GO has no molecular function term capturing the chain-length-determining role of the type II PKS CLF/KSbeta subunit. The current IEA acyltransferase annotations mischaracterize this non-catalytic subunit as an enzyme; a dedicated term would let curators describe CLF accurately (cf. the non-catalytic PqsB partner of PqsBC).
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0016746
acyltransferase activity
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: InterPro-based (IEA) acyltransferase activity from the ketosynthase (thiolase-like) signature. ActI-ORF2 (CLF/KSbeta) descends from a ketosynthase but lacks an active site and is catalytically dead; the condensation activity belongs to the KS subunit within the KS-CLF complex.
Reason: Attributes a catalytic MF to a non-catalytic subunit. CLF contributes_to (is required for) the KS-CLF activity and sets chain length, but does not itself catalyze acyl transfer; the activity should be annotated to the type II PKS complex with a contributes_to qualifier.
Supporting Evidence:
PMID:15286722
Although CLF regulates chain length, it does not have an active site; KS must catalyze both chain initiation and elongation.
|
|
GO:0016747
acyltransferase activity, transferring groups other than amino-acyl groups
|
IEA
GO_REF:0000117 |
MARK AS OVER ANNOTATED |
Summary: Orthology-based (IEA) more-specific acyltransferase activity. Same issue as GO:0016746: it assigns catalysis to the non-catalytic CLF subunit.
Reason: CLF has no active site; this catalytic MF over-annotates the subunit. Better represented as contributes_to / annotation to the KS-CLF complex.
Supporting Evidence:
PMID:15286722
Although CLF regulates chain length, it does not have an active site; KS must catalyze both chain initiation and elongation.
|
Q: Should a contributes_to-qualified molecular function (or a dedicated "chain length factor" term) be the recommended annotation for type II PKS CLF subunits across the family, rather than enables acyltransferase activity?
Experiment: Reconstitute KS-CLF with CLF variants of differing length specificity to confirm that CLF, though non-catalytic, dictates chain length within the assembled complex.
Part of the BGC exemplar curation project (projects/BGC.md). MIBiG BGC0000194
(Streptomyces coelicolor A3(2), actinorhodin type II PKS). GenBank CAC44201.1 →
UniProt Q02062 (ACTI2_STRCO), gene actI-ORF2 / SCO5088.
ActI-ORF2 is the chain-length factor (CLF, KSβ) of the actinorhodin minimal
type II PKS. It is the non-catalytic partner of the ketosynthase (ActI-ORF1,
KSα): together they form the heterodimeric KS-CLF that polymerizes the actinorhodin
polyketide chain, with CLF determining the chain length.
genes/PSEAE/pqsB).contributes_to the KS-CLF activity / should be annotated to theenables.Add (NEW, via core_functions): GO:0034082 type II polyketide synthase complex
(CC) and GO:1901112 actinorhodin biosynthetic process (BP) — currently missing
from the GOA despite being well established.
Moriwaki et al. (bioRxiv 2025.10.26.684697) predict the KSα–KSβ/CLF heterodimer
(BGC0000194; CAC44200.1/CAC44201.1) at ipTM 0.96, matching PDB 1TQY.
id: Q02062
gene_symbol: actI-ORF2
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:100226
label: Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145)
description: >-
ActI-ORF2 (SCO5088) is the chain-length factor (CLF, KSbeta) of the actinorhodin
"minimal" type II polyketide synthase in Streptomyces coelicolor. It is the
non-catalytic partner of the ketosynthase ActI-ORF1 (KSalpha): together they form
the heterodimeric KS-CLF that polymerizes the poly-beta-keto chain of the aromatic
polyketide antibiotic actinorhodin. CLF is descended from a ketosynthase but lacks
an active site; it regulates the final polyketide chain length, while the KS
subunit carries out chain initiation and elongation. Chain elongation and the first
cyclization occur within an amphipathic tunnel at the KS-CLF heterodimer interface
(PMID:15286722; PDB 1TQY). This makes ActI-ORF2 a structural/specificity subunit
that is only functional as part of the assembled KS-CLF complex, directly analogous
to PqsB in the P. aeruginosa PqsBC condensing enzyme.
references:
- id: PMID:15286722
title: An antibiotic factory caught in action.
findings:
- statement: >-
CLF regulates polyketide chain length but has no active site; the KS subunit is
the catalytic one.
supporting_text: >-
Although CLF regulates chain length, it does not have an active site; KS must
catalyze both chain initiation and elongation.
- statement: >-
KS and CLF form a heterodimer; the polyketide is elongated in a tunnel at the
heterodimer interface.
supporting_text: >-
the actinorhodin KS-CLF, which shows polyketides being elongated inside an
amphipathic tunnel approximately 17 A in length at the heterodimer interface
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified; PDB 1TQY structure paper. Cached entry is abstract-only, but
the abstract explicitly states that CLF lacks an active site (non-catalytic).
- id: file:STRCO/actI-ORF2/actI-ORF2-notes.md
title: actI-ORF2 review notes (BGC project) with predicted-complex evidence
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
- id: GO_REF:0000117
title: Gene Ontology annotation based on Ensembl/EnsemblGenomes orthology
existing_annotations:
- term:
id: GO:0016746
label: acyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro-based (IEA) acyltransferase activity from the ketosynthase (thiolase-like)
signature. ActI-ORF2 (CLF/KSbeta) descends from a ketosynthase but lacks an
active site and is catalytically dead; the condensation activity belongs to the
KS subunit within the KS-CLF complex.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Attributes a catalytic MF to a non-catalytic subunit. CLF contributes_to (is
required for) the KS-CLF activity and sets chain length, but does not itself
catalyze acyl transfer; the activity should be annotated to the type II PKS
complex with a contributes_to qualifier.
supported_by:
- reference_id: PMID:15286722
supporting_text: >-
Although CLF regulates chain length, it does not have an active site; KS must
catalyze both chain initiation and elongation.
- term:
id: GO:0016747
label: acyltransferase activity, transferring groups other than amino-acyl groups
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: enables
review:
summary: >-
Orthology-based (IEA) more-specific acyltransferase activity. Same issue as
GO:0016746: it assigns catalysis to the non-catalytic CLF subunit.
action: MARK_AS_OVER_ANNOTATED
reason: >-
CLF has no active site; this catalytic MF over-annotates the subunit. Better
represented as contributes_to / annotation to the KS-CLF complex.
supported_by:
- reference_id: PMID:15286722
supporting_text: >-
Although CLF regulates chain length, it does not have an active site; KS must
catalyze both chain initiation and elongation.
core_functions:
- description: >-
Chain-length-factor (CLF/KSbeta) subunit of the heterodimeric KS-CLF (type II PKS)
complex with the ketosynthase ActI-ORF1; functions only as part of the assembled
complex. Although non-catalytic, it is required for actinorhodin biosynthesis and
determines the polyketide chain length (PMID:15286722; PDB 1TQY).
contributes_to_molecular_function:
id: GO:0016218
label: polyketide synthase activity
in_complex:
id: GO:0034082
label: type II polyketide synthase complex
directly_involved_in:
- id: GO:1901112
label: actinorhodin biosynthetic process
supported_by:
- reference_id: PMID:15286722
supporting_text: >-
the actinorhodin KS-CLF, which shows polyketides being elongated inside an
amphipathic tunnel approximately 17 A in length at the heterodimer interface
proposed_new_terms:
- proposed_name: polyketide chain length factor activity
proposed_definition: >-
The function of a catalytically inactive ketosynthase-like (KSbeta/CLF) subunit
that, as part of a type II polyketide synthase (KS-CLF) complex, determines the
number of chain-extension cycles and hence the final length of the nascent
polyketide chain, without itself catalyzing condensation.
justification: >-
GO has no molecular function term capturing the chain-length-determining role of
the type II PKS CLF/KSbeta subunit. The current IEA acyltransferase annotations
mischaracterize this non-catalytic subunit as an enzyme; a dedicated term would
let curators describe CLF accurately (cf. the non-catalytic PqsB partner of PqsBC).
suggested_questions:
- question: >-
Should a contributes_to-qualified molecular function (or a dedicated
"chain length factor" term) be the recommended annotation for type II PKS CLF
subunits across the family, rather than enables acyltransferase activity?
suggested_experiments:
- description: >-
Reconstitute KS-CLF with CLF variants of differing length specificity to confirm
that CLF, though non-catalytic, dictates chain length within the assembled complex.